These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
29. In Vitro Pharmacokinetic/Pharmacodynamic Modeling of HIV Latency Reversal by Novel HDAC Inhibitors Using an Automated Platform. Newhard W; Patel M; Cassaday J; Ballard J; Squadroni B; Wu G; Liu J; Yu W; Kozlowski J; Zuck P; Howell B; Hazuda D; Vargo R; Barnard R SLAS Discov; 2021 Jun; 26(5):642-654. PubMed ID: 33427012 [TBL] [Abstract][Full Text] [Related]
30. Combinations of Histone Deacetylase Inhibitors with Distinct Latency Reversing Agents Variably Affect HIV Reactivation and Susceptibility to NK Cell-Mediated Killing of T Cells That Exit Viral Latency. Covino DA; Desimio MG; Doria M Int J Mol Sci; 2021 Jun; 22(13):. PubMed ID: 34206330 [TBL] [Abstract][Full Text] [Related]
31. Histone Deacetylase Inhibitors Enhance CD4 T Cell Susceptibility to NK Cell Killing but Reduce NK Cell Function. Pace M; Williams J; Kurioka A; Gerry AB; Jakobsen B; Klenerman P; Nwokolo N; Fox J; Fidler S; Frater J; PLoS Pathog; 2016 Aug; 12(8):e1005782. PubMed ID: 27529554 [TBL] [Abstract][Full Text] [Related]
32. Activation of HIV transcription with short-course vorinostat in HIV-infected patients on suppressive antiretroviral therapy. Elliott JH; Wightman F; Solomon A; Ghneim K; Ahlers J; Cameron MJ; Smith MZ; Spelman T; McMahon J; Velayudham P; Brown G; Roney J; Watson J; Prince MH; Hoy JF; Chomont N; Fromentin R; Procopio FA; Zeidan J; Palmer S; Odevall L; Johnstone RW; Martin BP; Sinclair E; Deeks SG; Hazuda DJ; Cameron PU; Sékaly RP; Lewin SR PLoS Pathog; 2014 Oct; 10(10):e1004473. PubMed ID: 25393648 [TBL] [Abstract][Full Text] [Related]
33. Small Molecule Inhibitors of BAF; A Promising Family of Compounds in HIV-1 Latency Reversal. Stoszko M; De Crignis E; Rokx C; Khalid MM; Lungu C; Palstra RJ; Kan TW; Boucher C; Verbon A; Dykhuizen EC; Mahmoudi T EBioMedicine; 2016 Jan; 3():108-121. PubMed ID: 26870822 [TBL] [Abstract][Full Text] [Related]
34. Chidamide, a histone deacetylase inhibitor-based anticancer drug, effectively reactivates latent HIV-1 provirus. Yang W; Sun Z; Hua C; Wang Q; Xu W; Deng Q; Pan Y; Lu L; Jiang S Microbes Infect; 2018; 20(9-10):626-634. PubMed ID: 29126877 [TBL] [Abstract][Full Text] [Related]
35. Novel histone deacetylase inhibitors CG05 and CG06 effectively reactivate latently infected HIV-1. Choi BS; Lee HS; Oh YT; Hyun YL; Ro S; Kim SS; Hong KJ AIDS; 2010 Feb; 24(4):609-11. PubMed ID: 20154582 [TBL] [Abstract][Full Text] [Related]
36. HIV-1 reactivation induced by apicidin involves histone modification in latently infected cells. Lin S; Zhang Y; Ying H; Zhu H Curr HIV Res; 2011 Jun; 9(4):202-8. PubMed ID: 21631428 [TBL] [Abstract][Full Text] [Related]
37. The novel histone deacetylase inhibitors metacept-1 and metacept-3 potently increase HIV-1 transcription in latently infected cells. Shehu-Xhilaga M; Rhodes D; Wightman F; Liu HB; Solomon A; Saleh S; Dear AE; Cameron PU; Lewin SR AIDS; 2009 Sep; 23(15):2047-50. PubMed ID: 19609198 [TBL] [Abstract][Full Text] [Related]
38. The differential short- and long-term effects of HIV-1 latency-reversing agents on T cell function. Clutton G; Xu Y; Baldoni PL; Mollan KR; Kirchherr J; Newhard W; Cox K; Kuruc JD; Kashuba A; Barnard R; Archin N; Gay CL; Hudgens MG; Margolis DM; Goonetilleke N Sci Rep; 2016 Aug; 6():30749. PubMed ID: 27480951 [TBL] [Abstract][Full Text] [Related]
39. Ex Vivo Bioactivity and HIV-1 Latency Reversal by Ingenol Dibenzoate and Panobinostat in Resting CD4(+) T Cells from Aviremic Patients. Spivak AM; Bosque A; Balch AH; Smyth D; Martins L; Planelles V Antimicrob Agents Chemother; 2015 Oct; 59(10):5984-91. PubMed ID: 26169416 [TBL] [Abstract][Full Text] [Related]
40. Histone deacetylase inhibitors impair the elimination of HIV-infected cells by cytotoxic T-lymphocytes. Jones RB; O'Connor R; Mueller S; Foley M; Szeto GL; Karel D; Lichterfeld M; Kovacs C; Ostrowski MA; Trocha A; Irvine DJ; Walker BD PLoS Pathog; 2014 Aug; 10(8):e1004287. PubMed ID: 25122219 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]